Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 30, 2024

Conditions

HIV-1-infectionDRMDRM Gene MutationART

Interventions

OTHER

no intervention

Trial Locations (1)

Department of Infectious Diseases, Tropical Diseases and Hepatology, Medical University of Warsaw, Warsaw

All Listed Sponsors

lead

Medical University of Warsaw

OTHER